Delivery Order SPE2DX22D0010-SPE2D825FFE19
- Not listed
- The Defense Logistics Agency awarded a $1,290.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for XTAMPZA ER 9 mg capsules (100-count units) with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of XTAMPZA ER CAPS 36MG. The award has a ceiling value of $5,229.60 and an ultimate completion date of August 14, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xtampza ER 27 mg capsules (100-count units) on September 12, 2025, with a ceiling value of $1,092.43. This firm fixed price delivery order has an ultimate completion date of September 15, 2025, and represents a non-competitive award under a larger contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Xtampza ER 13.5 mg capsules (100-count units) with a ceiling value of $2,302.80. This is a firm fixed-price delivery order with no set-aside designation, executed under open competition. The ultimate completion date is July 23, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,863.30 firm fixed-price delivery order is for the supply of XTAMPZA ER 36 MG capsules. The contract has an ultimate completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The Defense Logistics Agency awarded a $3,990.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Xtampza ER 36 mg, a pharmaceutical product for pain management. This non-set-aside competitive award was issued on October 31, 2025, with an ultimate completion date of November 3, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,787.26, is for the delivery of XTAMPZA ER CAPS 36MG, a pharmaceutical product. The contract has a completion date of November 21, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,703.99 to AmerisourceBergen Drug Corp for 100 capsules of Xtampza ER 36 mg, a long-acting opioid pain medication. The contract was competitively awarded with no set-aside designation, utilizing firm fixed pricing under a delivery order contract type. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,871.08, is for the delivery of XTAMPZA ER 18 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XTAMPZA ER 18 MG CAPSULE 100S, a pharmaceutical product, with a firm fixed price ceiling value of $1,663.38 and a performance period ending on May 19, 2025. The contract is not designated as a set-aside and is an open competition award. Amerisourcebergen Drug Corp is the...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FFE19Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,299.87 to AmerisourceBergen Drug Corp for XTAMPZA ER CAPS 13.5MG, a pharmaceutical product. The contract was competitively awarded without a set-aside designation on April 23, 2025, with an ultimate completion date of April 24, 2025. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. The award employs firm fixed price terms, typical of delivery orders under larger contract vehicles supporting federal medical procurement. This delivery order represents a task under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania and serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other government healthcare systems through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/23/25 |